S18-485 Pluripotent-specific, inducible safety switch to eliminate residual stem cells following differentiation Despite their rapidly expanding therapeutic potential, human pluripotent stem cell (hPSC)-derived cell therapies continue to have serious safety risks. Matthew Porteus Michael Cromer Renata Martin Kyle Loh Jonas Fowler